博济医药：子公司“卿芷软膏”获药物临床试验批准

Core Viewpoint - The announcement indicates that the company's wholly-owned subsidiary, Guangzhou Boji New Drug Clinical Research Center Co., Ltd., has received approval from the National Medical Products Administration for the clinical trial of "Qingzhi Ointment," which is aimed at treating knee osteoarthritis [1] Group 1 - The drug name is Qingzhi Ointment, and it is classified as a traditional Chinese medicine under category 1.1 [1] - The approval notification number is 2025LP02962 [1]